Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406 Yanhong Zhu,Ellen Herlaar,et al. Toxicology and Applied Pharmacology 2007;221:268–277
Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey. Sweeny DJ et al. Xenobiotica. 2010 Jun;40(6):415-23.
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.